Robert E. Desjardins
No más puestos en curso
Perfil
Robert E.
Desjardins is the founder of AkaRx, Inc. (founded in 2005) and Drais Pharmaceuticals Inc. (founded in 2007).
At AkaRx, Inc., he held the title of President & Chief Executive Officer from 2005 to 2010.
At Drais Pharmaceuticals Inc., he held the title of Director from 2010 to 2018.
In addition to his founding positions, Dr. Desjardins also held former jobs.
He worked as an Adjunct Professor at Georgetown University, as the Head-Anti-Infective Clinical Research at The Burroughs Wellcome Fund, and as a Principal at Lederle Pharmaceuticals.
Dr. Desjardins obtained a doctorate degree from Loyola University of Chicago.
Antiguos cargos conocidos de Robert E. Desjardins.
| Empresas | Cargo | Fin |
|---|---|---|
Drais Pharmaceuticals Inc.
 Drais Pharmaceuticals Inc. Pharmaceuticals: MajorHealth Technology Drais Pharmaceuticals, Inc. manufactures pharmaceutical and provides therapeutic treatments. The company was founded by Donna L. Tempel and Robert E. Desjardins in 2007 and is headquartered in Bridgewater, NJ. | Fundador | 01/05/2018 |
| Lederle Pharmaceuticals | Corporate Officer/Principal | - |
The Burroughs Wellcome Fund
 The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Director Técnico/Científico/I+D | 06/05/2011 |
| Georgetown University | Corporate Officer/Principal | - |
AkaRx, Inc.
 AkaRx, Inc. Pharmaceuticals: MajorHealth Technology AkaRx, Inc. engages in the develop and manufacture of biopharmaceutical products for applications in hematology and therapeutic treatments for clinical-stage cancer. It offers thrombocytopenia treatment avatrombopag. The company was founded by Robert E. Desjardins and Donna Tempel in 2005 and is headquartered in NJ. | Fundador | - |
Formación de Robert E. Desjardins.
| Loyola University of Chicago | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
AkaRx, Inc.
AkaRx, Inc. Pharmaceuticals: MajorHealth Technology AkaRx, Inc. engages in the develop and manufacture of biopharmaceutical products for applications in hematology and therapeutic treatments for clinical-stage cancer. It offers thrombocytopenia treatment avatrombopag. The company was founded by Robert E. Desjardins and Donna Tempel in 2005 and is headquartered in NJ. | Health Technology |
Drais Pharmaceuticals Inc.
Drais Pharmaceuticals Inc. Pharmaceuticals: MajorHealth Technology Drais Pharmaceuticals, Inc. manufactures pharmaceutical and provides therapeutic treatments. The company was founded by Donna L. Tempel and Robert E. Desjardins in 2007 and is headquartered in Bridgewater, NJ. | Health Technology |
The Burroughs Wellcome Fund
The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Miscellaneous |
| Lederle Pharmaceuticals |
- Bolsa de valores
- Insiders
- Robert E. Desjardins
